Q-omics provides the consensus-scored MIR4762 profile across patient tissues and cancer cell-line models. MIR4762 expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, MIR4762 is differentially expressed in 3, with the highest sampling consensus in UCEC. Additionally, MIR4762 RNA expression shows 8,434 significant gene co-expression associations, with the highest sampling consensus in LAML. Together, these results highlight UVM, UCEC, and LAML as cancer lineages where MIR4762 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR4762 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR4762 survival associations across molecular data types. MIR4762 RNA expression shows survival associations in the most cancer types (13). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR4762 RNA expression–survival associations across cancer types. High MIR4762 expression shows unfavorable associations in UVM, KICH, SKCM and THYM, but favorable associations in STAD and GBM. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify UVM as the clearest survival context for MIR4762 RNA expression.
This table summarizes MIR4762 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 3. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for MIR4762. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR4762 shows lower tumor expression in UCEC and ESCA and higher tumor expression in HNSC. The UCEC box plot shows higher MIR4762 RNA expression in normal versus tumor tissue (log2 FC = −1.490, t-test p = .001).
This table shows molecular features associated with MIR4762 in patient tissues and cancer cell lines. In patient samples, MIR4762 shows the broadest associations at the RNA and protein expression levels, with LAML recurring as the lineage with the largest associated feature set.
